Health ❯ Healthcare

Clinical Research

Clinical Trials Patient Outcomes Drug Development Efficacy Studies Study Findings Drug Trials Drug Efficacy Epidemiology Randomized Controlled Trials Phase 3 Trials

40 ARTICLES

4d ago

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

The trial's results could reshape treatment choices for people with type 2 diabetes by offering much larger weight loss and tighter blood sugar control.

5 ARTICLES

4d ago

Johns Hopkins-Led Program Linked to 65% Drop in Hospital-Onset MRSA Bloodstream Infections

6 ARTICLES

2w ago

FDA Approves Isembyld, First Muscle‑Directed Therapy for Spinal Muscular Atrophy

9 ARTICLES

3w ago

Study Maps Eight Genetic Footprints That Explain About 85% of Prostate Cancers

3 ARTICLES

3w ago

Early B‑Cell Therapy Cuts Relapses but Not Two‑Year Disability in New MS Cohort

6 ARTICLES

3w ago

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

9 ARTICLES

3w ago

Novartis' Pelacarsen Fails Phase 3 After Lowering Lp(a)

4 ARTICLES

3w ago

Semaglutide Linked to Fewer Asthma Attacks and COPD Flare‑Ups in Large UK Analysis

3 ARTICLES

4w ago

EU Safety Committee Opens Class Review of Injectable Iron Over Low-Phosphate and Bone Risks

3 ARTICLES

4w ago

Mayo Clinic Platform Accelerate Launches Multiyear Pathway and Picks 12 Clinical AI Firms

9 ARTICLES

4w ago

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

4 ARTICLES

4w ago

Scripps Publishes ECG‑CLIP, an AI That Learns From Doctors’ ECG Reports to Boost Heart‑disease Detection

4 ARTICLES

4w ago

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

10 ARTICLES

4w ago

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

5 ARTICLES

4w ago

FDA Approves Rusfertide (Mimrylo) for Polycythemia Vera

9 ARTICLES

last mo.

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

Clinical Research

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

Sugar Heightens Antibiotic Damage to Gut Microbiome in Stem‑Cell Patients

Orforglipron Found Noninferior to Insulin Glargine for Major Heart Events

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

Johns Hopkins-Led Program Linked to 65% Drop in Hospital-Onset MRSA Bloodstream Infections

FDA Approves Isembyld, First Muscle‑Directed Therapy for Spinal Muscular Atrophy

Study Maps Eight Genetic Footprints That Explain About 85% of Prostate Cancers

Early B‑Cell Therapy Cuts Relapses but Not Two‑Year Disability in New MS Cohort

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

Never miss stories about

Clinical Research

Novartis' Pelacarsen Fails Phase 3 After Lowering Lp(a)

Semaglutide Linked to Fewer Asthma Attacks and COPD Flare‑Ups in Large UK Analysis

EU Safety Committee Opens Class Review of Injectable Iron Over Low-Phosphate and Bone Risks

Mayo Clinic Platform Accelerate Launches Multiyear Pathway and Picks 12 Clinical AI Firms

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

Scripps Publishes ECG‑CLIP, an AI That Learns From Doctors’ ECG Reports to Boost Heart‑disease Detection

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

FDA Approves Rusfertide (Mimrylo) for Polycythemia Vera

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

Never miss stories about

Clinical Research